FDA Requiring Stronger Safety Labels for Opioid Medications
MONDAY, Aug. 4, 2025 -- The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain medications to better highlight the risks of long-term use, including misuse, addiction, and overdose.
The updated FDA opioid safety labeling is based on new data from two large postmarketing observational studies, which showed serious risks from long-term use. Citing these findings, public input, and the lack of strong evidence supporting long-term effectiveness, the FDA is updating opioid safety labels to support treatment decisions based on the latest evidence.
"The death of almost 1 million Americans during the opioid epidemic has been one of the cardinal failures of the public health establishment," FDA Commissioner Marty Makary, M.D., M.P.H., said in a statement. "This long-overdue labeling change is only part of what needs to be done -- we also need to modernize our approval processes and postmarket monitoring so that nothing like this ever happens again."
The labeling changes will include clearer risk information; stronger dosing warnings; clarified use limits, including removing language that could be misinterpreted as supporting indefinite use; and treatment guidance, emphasizing that long-acting opioids should only be used when other treatments, including short-acting opioids, are ineffective.
The labels will also address safe discontinuation; overdose reversal agents; drug interactions, including combining opioids with gabapentinoids; additional risks with overdose, highlighting new information on postoverdose toxic leukoencephalopathy; and digestive health, including updates about possible esophageal complications.
The FDA is also requiring a new randomized, controlled clinical trial to directly assess the benefits and risks of long-term opioid use. The agency says it will closely monitor the trial's progress.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Buprenorphine Lowers Opioid OD Risk, But Only If Taken As Directed Long-Term
THURSDAY, Nov. 20, 2025 — The opioid addiction medication buprenorphine can dramatically lower risk of overdose among teenagers and young adults — but only if taken...
Fentanyl-Linked Overdose Deaths Among Seniors Soar 9,000% in 8 Years
TUESDAY, Oct. 14, 2025 — Fentanyl overdose deaths are surging among seniors, particularly in cases where the powerful opioid is mixed with stimulants like cocaine or...
Popular Painkiller, Tramadol, Less Effective, More Risky Than Thought, Evidence Review Says
THURSDAY, Oct. 9, 2025 — A widely prescribed opioid painkiller is not all it’s cracked up to be, a new evidence review has concluded. The opioid painkiller tramadol...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.